1,765
Participants
Start Date
March 22, 2011
Primary Completion Date
November 30, 2015
Study Completion Date
November 30, 2015
Tenofovir disoproxil fumarate (TDF)
Some participants will receive varying doses of TDF during pregnancy or breastfeeding as part of the larger study (IMPAACT 1077 PROMISE).
Soweto IMPAACT CRS, Johannesburg
Shandukani Research CRS, Johannesburg
Durban Paediatric HIV CRS, Durban
Umlazi CRS, Durban
Family Clinical Research Unit (FAM-CRU) CRS, Tygerberg
Blantyre CRS, Blantyre
Malawi CRS, Lilongwe
MU-JHU Research Collaboration (MUJHU CARE LTD) CRS, Kampala
Seke North CRS, Chitungwiza
St Mary's CRS, Chitungwiza
Harare Family Care CRS, Harare
Collaborators (1)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Gilead Sciences
INDUSTRY
National Institute of Allergy and Infectious Diseases (NIAID)
NIH